InvestSMART

Control Bionics Limited (ASX: CBL) - Announcements

- Current share price for CBL : $0.049

ASX company news and announcements for Control Bionics Limited (CBL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Control Bionics Limited (CBL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Control Bionics Limited (CBL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Control Bionics Limited (CBL)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$27 Quarterly Activities/Appendix 4C Cash Flow Report 31 Jan 2025 8:42AM $0.061 $0.049 fallen by 19.67%
$27 Notice Pursuant to Section 708A(5)(e) 20 Dec 2024 4:11PM $0.058 $0.049 fallen by 15.52%
$27 Notification regarding unquoted securities - CBL 20 Dec 2024 4:03PM $0.058 $0.049 fallen by 15.52%
$27 Notification regarding unquoted securities - CBL 20 Dec 2024 4:02PM $0.058 $0.049 fallen by 15.52%
$27 Appendix 2A - shortfall shares 20 Dec 2024 3:58PM $0.058 $0.049 fallen by 15.52%
$27 Shortfall placement 20 Dec 2024 3:55PM $0.058 $0.049 fallen by 15.52%
$27 Final Director's Interest Notice - Hawke 17 Dec 2024 5:34PM $0.063 $0.049 fallen by 22.22%
$27 Chair Appointment/Resignation 17 Dec 2024 5:30PM $0.063 $0.049 fallen by 22.22%
$27 First Half FY25 Business Update 17 Dec 2024 8:14AM $0.066 $0.049 fallen by 25.76%
$27 Notification of Investor Briefing 16 Dec 2024 1:04PM $0.065 $0.049 fallen by 24.62%
$27 Expansion into US Sports and Japanese Rehab Markets 16 Dec 2024 8:27AM $0.065 $0.049 fallen by 24.62%
$27 Change of Director's Interest Notice - Lismore 28 Nov 2024 4:00PM $0.061 $0.049 fallen by 19.67%
$27 Coffee Microcaps Meeting Presentation 8 Nov 2024 8:23AM $0.061 $0.049 fallen by 19.67%
$27 CBL to present at Coffee Microcaps Meeting 8 Nov 2024 8:22AM $0.061 $0.049 fallen by 19.67%
$27 Ceasing to be a substantial holder - Chapman 23 Oct 2024 10:04AM $0.067 $0.049 fallen by 26.87%
$27 Initial Director's Interest Notice - Straface 22 Oct 2024 5:08PM $0.067 $0.049 fallen by 26.87%
$27 Director Appointment - Straface 22 Oct 2024 4:31PM $0.067 $0.049 fallen by 26.87%
$27 Quarterly Activities/Appendix 4C Cash Flow Report 17 Oct 2024 9:45AM $0.069 $0.049 fallen by 28.99%
$27 Change of Director's Interest Notice - Heard 17 Oct 2024 9:43AM $0.069 $0.049 fallen by 28.99%
$27 Change of Director's Interest Notice - Steele 17 Oct 2024 9:43AM $0.069 $0.049 fallen by 28.99%
$27 Change of Director's Interest Notice - Lismore 17 Oct 2024 9:41AM $0.069 $0.049 fallen by 28.99%
$27 Change of Director's Interest Notice - Hawke 17 Oct 2024 9:39AM $0.069 $0.049 fallen by 28.99%
$27 Change in substantial holding - Nightingale 17 Oct 2024 8:18AM $0.069 $0.049 fallen by 28.99%
$27 Notice Pursuant to Section 708A(5)(e) 17 Oct 2024 8:18AM $0.069 $0.049 fallen by 28.99%
$27 Appendix 3G - underwriting options 16 Oct 2024 12:14PM $0.067 $0.049 fallen by 26.87%

151 - 175 of 642 results

Page 7 of 26

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.